In Vitro Osteogenic Response of Rat Bone Marrow Cells to bFGF and BMP-2 Treatments
Authors:
- Cezary KucharskiCKCezary Kucharski
- Takrima HaqueTHTakrima Haque
- Walter SebaldWSWalter Sebald
- Hasan UludağHUHasan Uludağ
- 1 February 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 443, 113-123
Abstract
Basic fibroblast growth factor (bFGF) and bone morphogenetic protein-2 (BMP-2) are actively pursued for stimulation of bone formation. To assess their promise for systemic therapy of osteoporosis, we ascertained the effects of bFGF and BMP-2 on bone marrow cells in vitro. Bone marrow cells were obtained from young (8 weeks) and adult (32 weeks) rats by femoral aspiration and were exposed to osteogenic medium (ie, basal medium with 10 mM beta-glycerolphosphate and 100 nM dexamethasone) containing the growth factors. The cell viability in osteogenic medium was reduced after 3 weeks but not if the concentration of beta-glycerolphosphate/dexamethasone was reduced to 3 mM/30 nM. Unlike BMP-2, bFGF at 2-50 ng/mL was capable of enhancing long-term cell viability. Continuous treatment of bone marrow cells for 3 weeks resulted in dose-dependent stimulation of mineralization by BMP-2, but not by bFGF, whose activity was optimal at 2-10 ng/mL. To explore the effect of short-term exposure, bone marrow cells were treated with growth factors for 1 week and subsequent mineralization was investigated. BMP-2 exposure increased the extent of mineralization, but bFGF was not effective after the short exposure. We concluded bFGF was more potent (ie, required lower concentration) for stimulating osteogenic parameters, but BMP-2 effects were lasting on the bone marrow cells.Keywords
This publication has 36 references indexed in Scilit:
- Bone Marrow Cells from Normal and Ovariectomized Rats Respond Differently to Basic Fibroblast Growth Factor and Bone Morphogenetic Protein 2 Treatment in VitroTissue Engineering, 2005
- BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffoldExperimental Cell Research, 2004
- The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscleArchives of Oral Biology, 2002
- Maintenance of Osteoblastic and Adipocytic Differentiation Potential with Age and Osteoporosis in Human Marrow Stromal Cell CulturesCalcified Tissue International, 2002
- Real‐time quantitative RT‐PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitroJournal of Cellular Biochemistry, 2002
- Effect of maturation on the osteogenic response of cultured stromal bone marrow cells to basic fibroblast growth factorBone, 2000
- Three-dimensional cellular development is essential for ex vivo formation of human boneNature Biotechnology, 2000
- BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐IIThe EMBO Journal, 2000
- A Cost-Effective Method for the Automatic Quantitative Analysis of Fibroblastic Colony-Forming UnitsCalcified Tissue International, 1999
- In Vitro Comparison of Aged and Young Osteogenic and Hemopoietic Bone Marrow Stem Cells and Their Derivative ColoniesJournal of Periodontology, 1996